NATIONAL HEALTHCARE CORP
For the period ended May 8, 2025. Filed Mar 28, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 8, 2025 · Filed Mar 28, 2025
Use the contents to explore the available documents and sections.
Contents
PAY VERSUS PERFORMANCE
| Year · Summary Compensation Table Total to PEO(1)($) · Compensation Actually Paid to PEO(3)($) · Average Summary Compensation Table Total for Non-PEO NEOs(2)($) · Average Compensation Actually Paid to Non-PEO NEOs(2)(3)($) · Value of Initial Fixed $100 Investment Based on: · Net Income($) · Adjusted Income Before Income Taxes(5)($) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total Share-holder Return(4)($) · S&P Healthcare Index Total Shareholder Return(4)($) | ||||||||
| 2024 | 2,154,574 | 2,650,982 | 1,323,467 | 1,696,113 | 145.07 | 146.89 | 101,927,000 | 105,289,000 |
| 2023 | 1,609,695 | 2,416,165 | 971,183 | 1,579,389 | 121.89 | 143.19 | 66,798,000 | 75,304,000 |
| 2022 | 1,159,207 | 1,048,455 | 696,866 | 600,179 | 75.58 | 140.30 | 22,445,000 | 45,505,000 |
| 2021 | 2,249,445 | 2,132,097 | 1,288,949 | 1,157,347 | 83.43 | 143.09 | 138,590,000 | 163,404,000 |
| 2020 | 1,278,366 | 786,671 | 760,448 | 370,710 | 79.20 | 113.45 | 41,871,000 | 76,270,000 |
| (1) | The principal executive officer (“PEO”) for each of the covered fiscal years is Stephen F. Flatt, who began serving as our Chief Executive Officer (“CEO”) in January 2017. |
| (2) | The non-PEO Named Executive Officers (“NEO’s”) represent the following individuals for each of the years shown: |
2024, 2023 and 2022 - B. Anderson Flatt, Senior Vice President and Chief Information Officer; Brian F. Kidd, Senior Vice President and Chief Financial Officer; Josh A. McCreary, Senior Vice President, General Counsel, and Secretary; R. Michael Ussery, President and Chief Operating Officer.
2021 and 2020 - B. Anderson Flatt, Senior Vice President and Chief Information Officer; Brian F. Kidd, Senior Vice President, Controller, and Principal Accounting Officer; Jeffrey R. Smith, Senior Vice President and Treasurer; R. Michael Ussery, President and Chief Operating Officer.
| (3) | To calculate Compensation Actually Paid (“CAP”) to the Chief Executive Officer and the average CAP to the other NEO’s, the following adjustments were made to Summary Compensation Table (“SCT”) total compensation for 2024. The fair value of stock awards includes the value of both restricted stock awards and stock option awards (in $’s): |
| Additions · Deductions | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Year | Summary Compensation Table($) | Fair Value of Stock Awards Granted During the Year, Outstanding and Unvested at Year-End($) | Change in Value of Stock Awards Granted in Any Prior Year, Outstanding and Unvested at Year-End($) | Change in Value of Stock Awards Granted in Any Prior Year, Vested During the Year($) | Fair Value of Awards Forfeited in Fiscal Year($) | Dividends Paid in Fiscal Year on Unvested Awards($) | Stock Awards Reported in SCT($) | Option Awards Reported in SCT($) | Compensation Actually Paid($) |
| Principal Executive Officer | |||||||||
| 2024 | 2,154,574 | 686,180 | 287,502 | 25,354 | — | 12,844 | (272,051) | (243,420) | 2,650,982 |
| Average for Other NEO’s | |||||||||
| 2024 | 1,323,467 | 489,322 | 214,340 | 20,664 | — | 7,328 | (157,802) | (201,207) | 1,696,113 |
| (4) | The comparison of total shareholder returns (“TSR”) assumes that $100 was invested on December 31, 2019, in NHC and the S&P Healthcare Index, and that dividends were reinvested when and as paid. The selected peer group is the S&P Healthcare Index. |
| (5) | Our company-selected measure, which is the measure we believe represents the most important financial performance not otherwise presented in the table above that we use to link CAP to our Company’s performance is adjusted income before income taxes, a non-GAAP measure. This measure takes income before income taxes and adds or subtracts the unrealized gain or losses on marketable equity securities, plus adds or subtracts the net income or loss attributable to noncontrolling interest. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.